Replies to post #231794 on Biotech Values

[dewophile]

hate to bust in your dialogue w DD but your point is well taken - in addition to the market share battle w GILD, if some revenue is deferred bc of Covid you may not quite make it back later on in full bc you may spread out the revenue in such a way that you end up in lower royalty tiers